Analytics and PsychoPharmacology Laboratory (APPL)
The mission of the Analytics and PsychoPharmacology Laboratory (APPL) is to advance innovative, scientifically rigorous approaches to the understanding, treatment, and prevention of addictions. We accomplish this by:
- Conducting transdisciplinary research in interrelated areas
- Training future scholars and clinicians
- Promoting active participation of program affiliates in relevant policy arenas
Dr. Sterling McPherson was just announced as the new President-Elect of Division 28 in the American Psychological Association. He also recently completed a 3-year term as the chair of the Interventions to Prevent and Treat Addictions (IPTA) panel through NIH.
Dr. Andre Miguel’s newest NIH grant proposal was officially funded! The title of the project is: App Based Contingency Management and Varenicline Telhealth Intervention for Rural Heavy-Drinking Smokers. This is a 5 year, $3+ million project.
Dr. Crystal Smith and her student, Tenzin Nordon, present at CPDD in Portland, 2026.
Dr. Smith’s presentation title: Barriers and Facilitators to Implementing Pharmacogenetic Testing in Opioid Use Disorder Treatment: A Quuantitative Assessment.
Tenzin’s presentation title: Pharmacogenetic Testing for Methadone Dosing: A Qualitative Study of Patient and Provider Perspectives.
APPL has been taking students to the annual CPDD conference every year since 2014. The picture is from CPDD in Portland, OR where our investigators hosted multiple students.
Dr. Ekaterina Burduli featured in a King 5 news segment “Washington newborns testing positive for drugs at alarming rates”
APPL is proud to announce three of our Research Coordinators accepted into their programs of choice, taking a huge step in their careers:
Rachel Ryan: Washington State University’s Doctor of Pharmacy program
Nikki Akana: Wayne State University’s Clinical Psychology Doctoral program
Sean Hovland: King’s College London Addictions Master of Science program
Program of Excellence in Addictions Research
APPL is one of several units housed within the larger Program of Excellence in Addictions Research (PEAR).